Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas. Schuster SJ, Huw LY, Bolen CR, Maximov V, et al. Blood 2024;143:822-832.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schuster SJ, Huw LY, Bolen CR, Maximov V, et al. Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas. Blood 2024;143:822-832.
PMID: 38048694